WQ

William Querbes

AP Alnylam Pharmaceuticals: 30 patents #15 of 213Top 8%
IS Icahn School Of Medicine At Mount Sinai: 6 patents #10 of 404Top 3%
AP Alynylam Pharmaceuticals: 2 patents #1 of 17Top 6%
DI Dana-Farber Cancer Institute: 2 patents #445 of 1,343Top 35%
FV Flagship Pioneering Innovations Vi: 1 patents #95 of 166Top 60%
📍 Westwood, MA: #8 of 265 inventorsTop 4%
🗺 Massachusetts: #2,653 of 88,656 inventorsTop 3%
Overall (All Time): #105,305 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 26–33 of 33 patents

Patent #TitleCo-InventorsDate
10125369 PCSK9 iRNA compositions and methods of use thereof Anna Borodovsky, Kallanthottathil G. Rajeev, Kevin Fitzgerald, Maria Frank-Kamenetsky, Martin Maier +4 more 2018-11-13
10125364 Compositions and methods for inhibiting expression of the ALAS1 gene Brian Bettencourt, Kevin Fitzgerald, Robert J. Desnick, Makiko Yasuda 2018-11-13
10119143 Compositions and methods for inhibiting expression of the ALAS1 gene Brian Bettencourt, Kevin Fitzgerald, Robert J. Desnick, Makiko Yasuda 2018-11-06
9771591 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Brian Bettencourt, Kevin Fitzgerald, Maria Frank-Kamenetsky, Stuart Milstein, Svetlana Shulga Morskaya 2017-09-26
9631193 Compositions and methods for inhibiting expression of the ALAS1 gene Brian Bettencourt, Kevin Fitzgerald, Makiko Yasuda, Robert J. Desnick 2017-04-25
9322018 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Brian Bettencourt, Kevin Fitzgerald, Maria Frank-Kamenetsky, Stuart Milstein, Svetlana Shulga Morskaya 2016-04-26
9193973 Compositions and methods for increasing erythropoietin (EPO) production William G. Kaelin, Jr., Victor Kotelianski, Brian Bettencourt 2015-11-24
9133461 Compositions and methods for inhibiting expression of the ALAS1 gene Brian Bettencourt, Kevin Fitzgerald, Robert J. Desnick, Makiko Yasuda 2015-09-15